Aclaris Therapeutics (ACRS) Other Non Operating Income (2016 - 2024)

Aclaris Therapeutics' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $1.9 million for Q2 2024.

• In Q2 2024, Other Non Operating Income fell 16.83% year-over-year to $1.9 million; the TTM figure through Jun 2024 stood at $8.4 million (up 31.29% YoY), while the FY2023 annual figure was $8.5 million, up 188.83% from the prior year.
• Other Non Operating Income was $1.9 million for Q2 2024 at Aclaris Therapeutics, down from $2.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.3 million in Q3 2023 to a low of -$851000.0 in Q3 2021.
• Historically, Other Non Operating Income has averaged $763722.2 across 5 years, with a median of $320000.0 in 2020.
• The sharpest annual moves came in 2021 and 2022: Other Non Operating Income tumbled 338.66% in 2021, then jumped 1522.47% in 2022.
• A 5-year view of Other Non Operating Income shows it stood at -$219000.0 in 2020, then jumped by 140.64% to $89000.0 in 2021, then soared by 1522.47% to $1.4 million in 2022, then soared by 51.59% to $2.2 million in 2023, then slipped by 14.66% to $1.9 million in 2024.
• The last three Other Non Operating Income figures came in at $1.9 million (Q2 2024), $2.0 million (Q1 2024), and $2.2 million (Q4 2023), per Business Quant data.